![1]()
News
COVID-19 in children: New cases down for third straight week
February 10, 2021
Children’s share of all new cases has risen for five consecutive weeks.
News
Are diagnosticians chasing COVID-linked zebras and missing horses?
February 9, 2021
In their desire to not miss MIS-C, doctors triggered a cascade of specialty consultations, follow-up testing, and an unwarranted diagnostic preoccupation with MIS-C.
![1]()
News
SARS-CoV-2 in hospitalized children and youth
February 9, 2021
Severity of illness in patients with MIS-C was associated with lower absolute lymphocyte count and increasing CRP.
![1]()
Opinion
The journey from burnout to wellbeing
February 8, 2021
Peers and hospital leaders can make a crucial difference in mitigating stress and burnout.
News
Rollout of COVID-19 monoclonal antibodies lacked unified plan: expert panel
February 8, 2021
Monoclonal antibodies are in ample supply, but a lack of a plan to administer them has led to major underutilization of these therapies.
News
Cardiac activity not uncommon after lifesaving measures stop
February 5, 2021
ECG and blood pressure monitoring identified resumption of cardiac activity in 14% of patients, all occurring in the 5 minutes after pulselessness.
![1]()
News
Poor sensitivity for blood cultures drawn after antibiotics
February 5, 2021
In patients with severe sepsis, what is the sensitivity of blood cultures drawn shortly after antibiotic initiation?
![1]()
News
Rheumatologic disease activity an important influencer of COVID-19 death risk
February 5, 2021
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVID-19.
![1]()
News
COVID-19 cases dropping in U.S., but variants threaten progress
February 5, 2021
"The continued proliferation of variants, variants that likely have increased transmissibility, that spread more easily, threatens to reverse these recent trends."
![1]()
News
Antidepressant may help COVID-19 patients avoid serious illness
February 5, 2021
Racetrack workers who developed COVID-19 and took a 2-week course of fluvoxamine did not have to be hospitalized and felt better after 2 weeks.
